Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Crizanlizumab Versus Placebo, with or without Hydroxyurea/Hydroxycarbamide, in Adolescent and Adult Patients with Sickle Cell Disease and Vaso-Occlusive Crises: A Randomized, Double-Blind, Phase III Study (STAND)

Miguel R. Abboud, MD, Jo Howard, MB, BChir, Rodolfo Cançado, Wally R Smith, MD, Birol Güvenç, MD, Noemi Espurz, Marine Weill, Mariane de Montalembert, MD PhD

Blood (2019) 134 (Supplement_1): 998.

https://doi.org/10.1182/blood-2019-125775

Published: 2019

Journal Articles

Established Prevention of Vaso-Occlusive Crises with Crizanlizumab Is Further Improved in Patients Who Follow the Standard Treatment Regimen: Post-Hoc Analysis of the Phase II Sustain Study

Darla K Liles, MD, Rodolfo Cançado, Julie Kanter, MD, Abdullah Kutlar, MD, Andreas Bruederle, Michael Shi, MD PhD, Federico Campigotto, Kenneth I. Ataga

Blood (2018) 132 (Supplement 1): 1082.

https://doi.org/10.1182/blood-2018-99-112201

Published: 2018

Journal Articles

Crizanlizumab 5.0 Mg/Kg Increased the Time to First on-Treatment Sickle Cell Pain Crisis: A Subgroup Analysis of the Phase II Sustain Study

Julie Kanter, MD, Abdullah Kutlar, MD, Darla Liles, Rodolfo Cançado, Andreas Bruederle, Michael Shi, MD PhD, Zewen Zhu, Kenneth I Ataga, MD

Blood (2017) 130 (Supplement 1): 613.

https://doi.org/10.1182/blood.V130.Suppl_1.613.613

Published: 2017

Journal Articles

SUSTAIN: A Multicenter, Randomized, Placebo-Controlled, Double-Blind, 12-Month Study to Assess Safety and Efficacy of SelG1 with or without Hydroxyurea Therapy in Sickle Cell Disease Patients with Sickle Cell-Related Pain Crises

Kenneth I. Ataga, MD, Abdullah Kutlar, MD, Julie Kanter, MD, Darla Liles, MD, Rodolfo Cancado, MD, PhD, João Friedrisch, MD PhD, Troy H. Guthrie, MD, Jennifer Knight-Madden, MBBS, PhD, Ofelia A. Alvarez, MD, Victor R. Gordeuk, MD, Sandra Gualandro, MD PhD, Marina Pereira Collela, MD PhD, Wally R. Smith, MD, Scott A. Rollins, PhD, Jonathan W. Stocker, PhD, Russell P. Rother, PhD

Blood (2016) 128 (22): 1.

https://doi.org/10.1182/blood.V128.22.1.1

Published: 2016

Journal Articles

Modulation of Hemolytic and Hemoglobin/Heme Scavenging Profiles in Sickle Cell Anemia, Hereditary Spherocytosis and Paroxysmal Nocturnal Hemoglobinuria

Fernanda F.C. Fabris, Flavia C. Leonardo, PhD, Rodolfo Cancado, MD, PhD, Rafaela Mendonça, B.Sc., Angelica A. Silveira, M.Sc., Kleber Yotsumoto Fertrin, MD, PhD, Sara Teresinha Olalla Saad, MD PhD, Fernando F. Costa, MD, PhD, Nicola Conran, PhD, Camila B. Almeida, PhD

Blood (2016) 128 (22): 1257.

https://doi.org/10.1182/blood.V128.22.1257.1257

Published: 2016

Journal Articles

No Association Was Found Between MTHFR and MTHFD1 SNPs and Vitamin Levels in People with Increased and Normal Erythropoiesis, after Compulsory Flour Fortification with Folic Acid

Maylla Rodrigues Lucena, Msc student, Clovis Paniz, PhD student, Juliano Felix Bertinato, PhD student, Patricia Mendonça da Silva Amorim, Msc student, Tamara Ramos Jorge, undergraduate student, Maria Stella Figueiredo, MD PhD, Rodolfo Cancado, MD PhD, Maria de Fatima Sonati, PhD, Magnun N N Santos, PhD, Vera Bláia-D'Avila, MD PhD, Elvira M Guerra-Shinohara, PhD

Blood (2014) 124 (21): 4877.

https://doi.org/10.1182/blood.V124.21.4877.4877

Published: 2014

Journal Articles

Impact of Labile Plasma Iron on Viability of Cultured Mononuclear Cells

Flavio Augusto Naoum, MD PhD, Idiberto José Zotarelli, Breno Pannia Esposito, PhD, José Carlos Barros, MD PhD, Rodolfo Cancado, MD PhD

Blood (2014) 124 (21): 4885.

https://doi.org/10.1182/blood.V124.21.4885.4885

Published: 2014

Journal Articles

Assessmet of Labile Plasma Iron and Hepcidin in Patients Who Undergo Hematopoietic Stem Cell Transplantation

Flávio Augusto Naoum, MDPhD, Breno Pannia Esposito, PhD, Milton Arthur Ruiz, MDPhD, Rodolfo Cancado, MD PhD, José Carlos Barros, MDPhD

Blood (2014) 124 (21): 4029.

https://doi.org/10.1182/blood.V124.21.4029.4029

Published: 2014

Journal Articles

Elevated Serum Folic Acid Concentrations Were Associated with Higher mRNA Expression of DHFR Gene in Patients with Hereditary Spherocytosis

Clovis Paniz, PhDstudent, Maylla Rodrigues Lucena, Msc student, Juliano Felix Bertinato, PhDstudent, Patricia Mendonça da Silva Amorim, Msc student, Guilherme Wataru Gomes, Msc student, Maria Stella Figueiredo, MD PhD, Ralph Green, MD PhD, Rodolfo Cancado, MD PhD, Claudia R Bonini Domingos, PhD, Vera Bláia-D'Avila, MD PhD, Marcelo Cliquet, MD PhD, Elvira Maria Guerra-Shinohara, PhD

Blood (2014) 124 (21): 4005.

https://doi.org/10.1182/blood.V124.21.4005.4005

Published: 2014

Journal Articles

Potential Benefits of Extended Genotype Matching to Chronically Transfused Patients with Sickle Cell Disease

Ricardo Helman, MD, Rodolfo Cancado, MD, PhD, Mariza A Mota, MD, Marcia R Dezan, Jose Mauro Kutner, MD, PhD, Carlos S Chiattone, MD, PhD, Lilian Castilho, PhD

Blood (2011) 118 (21): 2144.

https://doi.org/10.1182/blood.V118.21.2144.2144

Published: 2011

Journal Articles

Global Sequencing for the Molecular Background of Hereditary Hemochomatosis In Brazilian Patients

Elvira Maria Guerra-Shinohara, PhD, Paulo Caleb Santos, Rodolfo Cancado, MD, PhD, Alexandre Pereira, MD, PhD, Isolmar Schettert, MD, Renata Soares, Rosario D C Hirata, PhD, Mario H Hirata, PhD, Regina Pagliusi, Maria Stella Figueiredo, MD, PhD, José Eduardo Krieger, MD, PhD, Carlos Chiattone, MD, PhD

Blood (2010) 116 (21): 5146.

https://doi.org/10.1182/blood.V116.21.5146.5146

Published: 2010

Journal Articles

Deferasirox for the Treatment of Transfusional Iron Overload In Sickle Cell Anemia: a 2-Yr Prospective Study

Rodolfo Cancado, Maria Cristina Olivato, Paula Bruniera, Murilo Rezende Melo, Carlos Chiattone, MD, PhD

Blood (2010) 116 (21): 5148.

https://doi.org/10.1182/blood.V116.21.5148.5148

Published: 2010

Journal Articles

Analysis of Calcium Profile and Bone Mineral Density in Patients with Sickle Cell Disease

Lucila Macedo Gonçalves, Rodolfo Cancado, Tarissa Beatrice Zanata Petry, Murilo Rezende Melo, João Eduardo Salles, Nilza Maria Scalissi, Carlos Chiattone, MD, PhD

Blood (2010) 116 (21): 4810.

https://doi.org/10.1182/blood.V116.21.4810.4810

Published: 2010

Journal Articles

Efficacy and Safety of Deferasirox (Exjade®) in Patients with Transfusion- Dependent Anemias: Preliminary Results From the First, Retrospective, Multicenter Brazilian Study.

Blood (2009) 114 (22): 5096.

https://doi.org/10.1182/blood.V114.22.5096.5096

Published: 2009

Journal Articles

Latin American Registry of Patients (Pts) with Transfusional Hemosiderosis (Th): The RELATH Study.

Rodolfo Cancado, MD, Ivan Angulo, MD, Zaida Plumacher, MD, Mariela Moreno, MD, Adriana Linares, MD, Juan P. Zarate, MD

Blood (2007) 110 (11): 4013.

https://doi.org/10.1182/blood.V110.11.4013.4013

Published: 2007

NARROW

Crizanlizumab Versus Placebo, with or without Hydroxyurea/Hydroxycarbamide, in Adolescent and Adult Patients with Sickle Cell Disease and Vaso-Occlusive Crises: A Randomized, Double-Blind, Phase III Study (STAND)

Established Prevention of Vaso-Occlusive Crises with Crizanlizumab Is Further Improved in Patients Who Follow the Standard Treatment Regimen: Post-Hoc Analysis of the Phase II Sustain Study

Crizanlizumab 5.0 Mg/Kg Increased the Time to First on-Treatment Sickle Cell Pain Crisis: A Subgroup Analysis of the Phase II Sustain Study

SUSTAIN: A Multicenter, Randomized, Placebo-Controlled, Double-Blind, 12-Month Study to Assess Safety and Efficacy of SelG1 with or without Hydroxyurea Therapy in Sickle Cell Disease Patients with Sickle Cell-Related Pain Crises

Modulation of Hemolytic and Hemoglobin/Heme Scavenging Profiles in Sickle Cell Anemia, Hereditary Spherocytosis and Paroxysmal Nocturnal Hemoglobinuria

No Association Was Found Between MTHFR and MTHFD1 SNPs and Vitamin Levels in People with Increased and Normal Erythropoiesis, after Compulsory Flour Fortification with Folic Acid

Impact of Labile Plasma Iron on Viability of Cultured Mononuclear Cells

Assessmet of Labile Plasma Iron and Hepcidin in Patients Who Undergo Hematopoietic Stem Cell Transplantation

Elevated Serum Folic Acid Concentrations Were Associated with Higher mRNA Expression of DHFR Gene in Patients with Hereditary Spherocytosis

Potential Benefits of Extended Genotype Matching to Chronically Transfused Patients with Sickle Cell Disease

Global Sequencing for the Molecular Background of Hereditary Hemochomatosis In Brazilian Patients

Deferasirox for the Treatment of Transfusional Iron Overload In Sickle Cell Anemia: a 2-Yr Prospective Study

Analysis of Calcium Profile and Bone Mineral Density in Patients with Sickle Cell Disease

Efficacy and Safety of Deferasirox (Exjade®) in Patients with Transfusion- Dependent Anemias: Preliminary Results From the First, Retrospective, Multicenter Brazilian Study.

Latin American Registry of Patients (Pts) with Transfusional Hemosiderosis (Th): The RELATH Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only